AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Critical phosphorylation site for activation of ATM kinase (SJ-02-0008)

*Abstract

Ataxia Telangiectasia-Mutated (ATM) kinase is a large protein that plays a critical role in detecting and repairing double strand DNA breaks in the cell. The inventors have discovered that ATM kinase activation is exquisitely sensitive to DNA damage and occurs by phosphorylation of a specific serine residue at position 1981 on the ATM kinase protein. Activation of ATM kinase can now be directly detected using antibodies that specifically recognize only the activated, serine phosphorylated form of this enzyme. This provides a way to detect exposure to radiation, oxidative stress, and other DNA damaging agents or to gauge an individual's susceptibility to such agents. Screening methods for agents which can modulate ATM kinase activity are now possible based on this discovery. Inhibitors of ATM kinase are useful for enhancing the effects of radiation therapy. ATM kinase activators are contemplated to be useful to protect against cancers that arise from DNA damage.

Key words: ATM, DNA damage, radiosensitizer, cancer prevention

Granted patents or published applications: US Patent Nos. 6,916,627, 7,108,992, 7,160,692 and 7,279,290.

Related scientific references: Bakkenist, C. et al. " DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation", Nature 421: 499-506 (2003); see also related commentary by Bartek, J. and Lukas, J., Nature 421: 486-488 (2003);

Kastan, M.B. and Bartek, J., "Cell-cycle checkpoints and cancer", Nature 432: 316-323 (2004) .

Country/Region
USA

For more information, please click Here
Mobile Device